ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
ProPhase Labs, Inc. (PRPH)
US:NASDAQ Investor Relations:
prophaselabs.com/investors/annual-reports
Company Research
Source: GlobeNewswire
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives Expected to Begin in Early 2026 UNIONDALE, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) today announced that its study, “Assessing Risk of Progression in Barrett’s Esophagus Using a Mass-Spectrometry-Based Proteomic Panel,” has been published online in Clinical and Translational Gastroenterology, the official journal of the American College of Gastroenterology (ACG). The publication presents full clinical validation data supporting BE-Smart, an 8-protein, mass-spectrometry-based proteomic assay developed for risk stratification of patients with Barrett’s Esophagus (BE). Conducted in collaboration with the Mayo Clinic, the study demonstrates that BE-Smart provides a highly accurate, molecularly driven method for identifying BE patients most l
Show less
Read more
Impact Snapshot
Event Time:
PRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRPH alerts
High impacting ProPhase Labs, Inc. news events
Weekly update
A roundup of the hottest topics
PRPH
News
- ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value [Yahoo! Finance]Yahoo! Finance
- ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset ValueGlobeNewswire
- ProPhase Labs (NASDAQ:PRPH) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PRPH&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen<MarketBeat
- ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript [Seeking Alpha]Seeking Alpha
- ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... [Yahoo! Finance]Yahoo! Finance
PRPH
Earnings
- 8/13/25 - Beat
PRPH
Sec Filings
- 1/9/26 - Form 8-K
- 1/9/26 - Form 8-K
- 1/2/26 - Form 8-K
- PRPH's page on the SEC website